While we are stock-pickers, we do not ignore the business cycle; analysing it helps us determine when to allocate capital to certain companies.
When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
Optimism ahead of 29 March exit date
We are all tired of talking about backstops and customs unions and voting blocs, but Brexit chat still manages to get centre stage to the exclusion of all else.
Brexit and general election risk